|1.||Bjerrum, Lars: 2 articles (01/2009 - 06/2002)|
|2.||Schønheyder, Henrik Carl: 2 articles (04/2008 - 11/2003)|
|3.||Skriver, Mette Vinther: 2 articles (04/2008 - 11/2003)|
|4.||Sørensen, Henrik Toft: 2 articles (04/2008 - 11/2003)|
|5.||Nørgaard, Mette: 2 articles (04/2008 - 11/2003)|
|6.||Poulsen, Henrik E: 1 article (07/2013)|
|7.||Jimenez-Solem, Espen: 1 article (07/2013)|
|8.||Torp-Pedersen, Christian: 1 article (07/2013)|
|9.||Klarskov, Pia: 1 article (07/2013)|
|10.||Andersen, Jon Trærup: 1 article (07/2013)|
|1.||Urinary Tract Infections (Urinary Tract Infection)
10/01/1989 - "Single-dose versus conventional six-day therapy with sulfamethizole for asymptomatic urinary tract infection in pregnant women was investigated in a prospective, randomised open study. "
05/01/1960 - "A clinical and laboratory study of combined mendelamine and thiosulfil in resistant urinary tract infections."
02/24/1986 - "[Urinary tract infection in general practice treated with sulfamethizole in a single dose or for 6 days]."
01/01/1981 - "A 35-year-old man had been treated with sulfamethizole on 6 occasions because of recurrent urinary tract infections. "
09/01/1954 - "Thiosulfil in urinary tract infection."
03/01/2003 - "Infection with a sulII gene-positive strain (MIC, >2,048 micro g/ml) could not be treated with sulfamethizole, as no effect could be demonstrated in the urine, bladder, or kidneys. "
12/13/1993 - "Four weeks previously she had been treated with sulphamethizole for a bladder infection. "
08/01/1979 - "Several treatment regimes were assessed, and of these it appeared that sulphamethizole 1g three times a day was most effective, both in terms of a lower rate of relapse of infection and also a low incidence of side effects."
09/21/1981 - "[Patients with symptoms of acute urinary infections treated with piromidic acid or sulfamethizole in general practice. "
05/01/1961 - "A clinical report on the use of combined mandelamine and thiosulfil in resistant urinarv tract infections."
|3.||Spontaneous Abortion (Miscarriage)
11/01/2003 - "There was an increased risk of miscarriage after exposure to sulfamethizole during the week before miscarriage, but further studies are needed to evaluate whether this increased risk is causal."
11/01/2003 - "We used data from the Prescription Database, the Birth Registry and the Hospital Discharge Registry in North Jutland County to study any association between sulfamethizole use and first recorded miscarriage. "
11/01/2003 - "The case-control analysis included 3347 women who had a miscarriage, of whom 90 had taken sulfamethizole, and 22599 primiparous controls who had a live birth. "
11/01/2003 - "To estimate the risk of adverse birth and neonatal outcome, and miscarriage in women who used sulfamethizole during pregnancy. "
11/01/2003 - "Among women who received prescriptions for sulfamethizole, adjusted odds ratios and 95% confidence intervals for adverse birth outcome were: malformation 1.17 (0.95-1.43); low birth weight 0.69 (0.49-0.98); pre-term birth 1.12 (0.97-1.30); stillbirth 1.02 (0.61-1.68); neonatal jaundice 1.14 (0.38-3.46); and for receiving a prescription for sulfamethizole within 1 week before miscarriage 1.66 (0.92-2.99). "
11/29/1999 - "[Is sulfamethizole in acute cystitis not useful anymore?]."
01/01/2009 - "At the follow-up visit 7-10 days after initiation of treatment, 95.4% of patients treated with pivmecillinam and 92.6% of patients treated with sulfamethizole had no persistent cystitis symptoms (difference 2.8%, CI -4.5%; 10.0%). "
01/01/2009 - "Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial."
11/01/2012 - "Cystitis antibiotics consisted of pivmecillinam, sulphamethizole and nitrofurantoin. "
07/01/2013 - "We found no association between redeeming a prescription of sulfamethizole near term and increased risk of neonatal jaundice. "
07/01/2013 - "The OR of developing neonatal jaundice after exposure to sulfamethizole was 2.35 (95% confidence interval [CI] 2.02-2.72). "
07/01/2013 - "Of 1,823 (0.2%) neonates exposed to sulfamethizole up to 4 weeks before birth, 197 (10.8%) developed neonatal jaundice. "
07/01/2013 - "To investigate the association between maternal use of sulfamethizole near term and the risk of neonatal jaundice. "
11/01/2003 - "We found no increased risk of congenital malformation, stillbirth or pre-term birth, and no association between use of sulfamethizole late in pregnancy and risk of neonatal jaundice. "
|2.||Amdinocillin Pivoxil (Pivmecillinam)
|4.||Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)
|6.||trimethoprim drug combination sulfadiazine